Home › Funds › Lion Point Capital, LP › BNTC
Lion Point Capital, LP position in BNTC
BENITEC BIOPHARMA INC · Health Care
Lion Point Capital, LP reported holding 62,000 shares of BNTC (BENITEC BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$830K, representing 3.97% of its reported portfolio and ranking #8 among its reported holdings. Lion Point Capital, LP has disclosed BNTC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lion Point Capital, LP's BNTC position evolved
Lion Point Capital, LP first disclosed a stake in BNTC in Q3 2024 at 39,000 shares (US$358K). The position peaked in Q3 2025 at 62,000 shares, worth US$870K. Across 8 filings, Lion Point Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 62,000 shares valued at US$830K. Notable position changes include a 59% increase in Q4 2024 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 39.00K | $358.41K | New |
| Q4 2024 | 62.00K | $783.06K | Add |
| Q1 2025 | 62.00K | $806.62K | Hold |
| Q2 2025 | 62.00K | $725.40K | Hold |
| Q3 2025 | 62.00K | $869.86K | Hold |
| Q4 2025 | 62.00K | $835.14K | Hold |
| Q1 2026 | 62.00K | $660.30K | Hold |
| Q2 2026 | 62.00K | $829.56K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNTC and 13F data
BNTC (BENITEC BIOPHARMA INC) is a Health Care company. 56 other funds we track also report a position in BNTC — the largest reported positions include MONTANOVA CAPITAL, LLC (US$154.5M), Nantahala Capital Management, LLC (US$19.9M), Simplify Asset Management Inc. (US$13.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTC
- MONTANOVA CAPITAL, LLC 11.55M sh · $154.52M · Q2 2026
- Nantahala Capital Management, LLC 1.49M sh · $19.91M · Q2 2026
- Simplify Asset Management Inc. 1.01M sh · $13.45M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 923.01K sh · $12.35M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 679.83K sh · $9.10M · Q2 2026
- MYDA Advisors LLC 250.00K sh · $3.35M · Q2 2026
More on Lion Point Capital, LP
FAQ
How long has Lion Point Capital, LP held BNTC?
Lion Point Capital, LP has disclosed BNTC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is Lion Point Capital, LP's current position in BNTC?
As of Q2 2026, Lion Point Capital, LP holds 62.00K shares of BNTC (BENITEC BIOPHARMA INC), valued at $829.56K, representing 3.97% of its reported portfolio and ranking #8.
Has Lion Point Capital, LP been buying or selling BNTC?
In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in BNTC. The position peaked in Q3 2025 at 62.00K shares.
Which other funds hold BNTC?
Other major institutional holders of BNTC include MONTANOVA CAPITAL, LLC, Nantahala Capital Management, LLC, Simplify Asset Management Inc., among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.